{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:43:40Z","timestamp":1789386220125,"version":"build-2803163510"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Mifepristone-misoprostol treatment for medical abortion and miscarriage are safe and effective. This study aimed to assess clinical factors associated with subsequent surgical intervention after medical termination of early viable or non-viable pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective, single-center study included women who underwent medical abortion at Taipei Medical University between January 2010 and December 2019. A total of 1,561 subjects, with 1,080 viable and 481 non-viable pregnancies, who were treated with oral mifepristone 600 mg followed by misoprostol 600 mg 48 h later were included. Data of all pregnancies and medical termination of pregnancy were evaluated using regression analysis. The main outcome was successful termination of pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The success rate of medical abortion was comparable in women with viable and non-viable (92.13% vs. 92.93%) pregnancies. Besides retained tissue, more existing pregnancies with ultrasonographic findings were found in the non-viable pregnancy group than in the viable pregnancy group (29.4% vs. 14.1%, <jats:italic>p<\/jats:italic> = 0.011). Multivariate analysis showed that previous delivery was an independent risk factor for failed medical abortion among all included cases. In women with viable pregnancy, longer gestational age [adjusted odds ratio (aOR): 1.483, 95% confidence interval (CI): 1.224\u20131.797, <jats:italic>p<\/jats:italic> &amp;lt; 0.001] and previous Cesarean delivery (aOR: 2.177, 95% CI: 1.167\u201340.62, <jats:italic>p<\/jats:italic> = 0.014) were independent risk factors for failed medical abortion. Number of Cesarean deliveries (aOR: 1.448, 95% CI: 1.029\u20132.039, <jats:italic>p<\/jats:italic> = 0.034) was an independent risk factor for failed medication abortion in women with non-viable pregnancies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This is the first cohort study to identify risk factors for subsequent surgical intervention in women with viable or non-viable pregnancies who had undergone early medically induced abortions. The success rate of medical abortion is comparable in women with viable and non-viable pregnancies. Previous delivery is an independent risk factor for failed medical abortion. Clinical follow-up may be necessary for women who are at risk of subsequent surgical intervention.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1188629","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T04:55:01Z","timestamp":1714107301000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical factors associated with subsequent surgical intervention in women undergoing early medical termination of viable or non-viable pregnancies"],"prefix":"10.3389","volume":"11","author":[{"given":"Heng-Kien","family":"Au","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wei","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1097\/AOG.0000000000002899","article-title":"ACOG practice bulletin no. 200: early pregnancy loss.","volume":"132","year":"2018","journal-title":"Obstet Gynecol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1097\/AOG.0000000000004082","article-title":"Medication abortion up to 70 days of gestation: ACOG practice bulletin, number 225.","volume":"136","year":"2020","journal-title":"Obstet Gynecol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States.","volume":"338","author":"Spitz","year":"1998","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/s0010-7824(00)00187-6","article-title":"Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost.","volume":"62","author":"Bartley","year":"2000","journal-title":"Contraception."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1046\/j.1471-0528.2002.02156.x","article-title":"Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases.","volume":"109","author":"Ashok","year":"2002","journal-title":"Bjog."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1093\/humrep\/13.10.2962","article-title":"An effective regimen for early medical abortion: a report of 2000 consecutive cases.","volume":"13","author":"Ashok","year":"1998","journal-title":"Hum Reprod."},{"key":"B7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/01.AOG.0000206737.68709.3e","article-title":"Factors related to successful misoprostol treatment for early pregnancy failure.","volume":"107","author":"Creinin","year":"2006","journal-title":"Obstet Gynecol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/AOG.0b013e31819638e6","article-title":"Effect of previous live birth and prior route of delivery on the outcome of early medical abortion.","volume":"113","author":"Chien","year":"2009","journal-title":"Obstet Gynecol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.contraception.2015.08.010","article-title":"Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol.","volume":"93","author":"Reeves","year":"2016","journal-title":"Contraception."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2019.02.014","article-title":"Risk factors for surgical intervention of early medical abortion.","volume":"220","author":"Meaidi","year":"2019","journal-title":"Am J Obstet Gynecol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/aogs.13780","article-title":"Efficacy of mifepristone and misoprostol for medical treatment of missed miscarriage in clinical practice-A cohort study.","volume":"99","author":"Ehrnst\u00e9n","year":"2020","journal-title":"Acta Obstet Gynecol Scand."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002855.pub5","article-title":"Medical methods for first trimester abortion.","volume":"2011","author":"Kulier","year":"2011","journal-title":"Cochrane Database Syst Rev."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002253.pub4","article-title":"Medical treatment for early fetal death (less than 24 weeks).","volume":"6","author":"Lemmers","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1056\/NEJMoa1715726","article-title":"Mifepristone pretreatment for the medical management of early pregnancy loss.","volume":"378","author":"Schreiber","year":"2018","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/humupd\/dmz002","article-title":"Management of first-trimester miscarriage: a systematic review and network meta-analysis.","volume":"25","author":"Al Wattar","year":"2019","journal-title":"Hum Reprod Update."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.04.006","article-title":"Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial.","volume":"223","author":"Sonalkar","year":"2020","journal-title":"Am J Obstet Gynecol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5395\/rde.2017.42.2.152","article-title":"Statistical notes for clinical researchers: chi-squared test and Fisher\u2019s exact test.","volume":"42","author":"Kim","year":"2017","journal-title":"Restor Dent Endod."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.fertnstert.2005.09.055","article-title":"Influence of parity on first trimester endovascular trophoblast invasion.","volume":"85","author":"Prefumo","year":"2006","journal-title":"Fertil Steril."},{"key":"B19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.contraception.2005.09.007","article-title":"Termination of pregnancy in patients with previous cesarean section.","volume":"73","author":"Mazouni","year":"2006","journal-title":"Contraception."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.crwh.2021.e00364","article-title":"Combined vesicouterine rupture during second-trimester medical abortion for fetal abnormality after prior cesarean delivery: A case report.","volume":"32","author":"Caruso","year":"2021","journal-title":"Case Rep Womens Health."},{"key":"B21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/uog.5200","article-title":"Deficient lower-segment Cesarean section scars: prevalence and risk factors.","volume":"31","author":"Ofili-Yebovi","year":"2008","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/uog.14877","article-title":"Association between ultrasonographic parameters of Cesarean scar defect and outcome of early termination of pregnancy.","volume":"47","author":"Au","year":"2016","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100716","article-title":"Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial.","volume":"32","author":"Hamel","year":"2021","journal-title":"EClinicalMedicine."},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101721","article-title":"Serum progesterone levels could predict diagnosis, completion and complications of miscarriage.","volume":"49","author":"Blavier","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1188629\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T04:55:05Z","timestamp":1714107305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1188629\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":24,"alternative-id":["10.3389\/fmed.2024.1188629"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1188629","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]},"article-number":"1188629"}}